SCULPTRA is an aesthetic treatment made from poly-L-lactic acid. It is FDA-approved for the treatment of HIV-associated lipoatrophy. It is intended for administration into the deep dermis or subcutaneous layer. Poly-L-lactic acid is a synthetic polymer made to replicate lactic acid, a natural derivative created by the muscles during exercise.
Meant for the treatment of lipoatrophy, SCULPTRA is also used for the correction of wrinkles and folds. The product initially adds some volume and then stimulates new collagen production as the poly-L-lactic acid microparticles are absorbed, leading to long-term results. It is excellent for adding all-over volume rather than treating just one or two spots.
Indicated for the treatment of mild-to-severe facial wrinkles and hollows, SCULPTRA can be used for Marionette Lines, Nasolabial Folds, and Tear Troughs, as well as for replacing lost volume in the cheeks, the chin, and the temples.
Unlike other dermal fillers, SCULPTRA provides gradual results that become evident over a period of months thanks to the stimulation of collagen production – this process is called Neocollagenesis. Suggested treatment protocol is three sessions, spaced a month to a month-and-a-half apart, and since the effects may last up to two years, top-ups are rarely necessary.
SCULPTRA contains poly-L-lactic acid and comes in the form of a sterile freeze-dried powder that also has sodium carboxymethyl-cellulose and non-pyrogenic mannitol. Poly-L-lactic acid has a 30-year track record as a safe, biodegradable substance that has been successfully used in surgical stitches. Each package contains one or two vials of powder which are to be reconstituted with sterile water. SCULPTRA is manufactured by Sinclair Pharma.